783265-75-8

Usage

Uses

Used in Pharmaceutical Industry:
Nω,Nω-Dimethyl-L-arginine (asymmetrical) is used as a therapeutic target for the development of drugs aimed at treating cardiovascular diseases. By modulating the levels of ADMA, these drugs can potentially improve cardiovascular function and reduce the risk of hypertension and atherosclerosis.
Used in Diagnostics:
ADMA is used as a biomarker for the assessment of endothelial dysfunction, which is an early indicator of cardiovascular diseases. Measuring ADMA levels in blood can help in the early detection and monitoring of cardiovascular health.
Used in Research:
Nω,Nω-Dimethyl-L-arginine (asymmetrical) is used as a research tool to study the regulation of nitric oxide and its implications for cardiovascular health. Understanding the role of ADMA in nitric oxide synthesis can provide insights into the development of novel therapeutic strategies for cardiovascular diseases.
Used in Nutritional Supplements:
ADMA may be used as an ingredient in nutritional supplements designed to support cardiovascular health. By providing a natural means to regulate nitric oxide production, these supplements can potentially help maintain healthy blood pressure and vascular function.

Relevant academic research and scientific papers

Binding Methylarginines and Methyllysines as Free Amino Acids: A Comparative Study of Multiple Host Classes**

Methylated free amino acids are an important class of targets for host-guest chemistry that have recognition properties distinct from those of methylated peptides and proteins. We present comparative binding studies for three different host classes that are each studied with multiple methylated arginines and lysines to determine fundamental structure-function relationships. The hosts studied are all anionic and include three calixarenes, two acyclic cucurbiturils, and two other cleft-like hosts, a clip and a tweezer. We determined the binding association constants for a panel of methylated amino acids using indicator displacement assays. The acyclic cucurbiturils display stronger binding to the methylated amino acids, and some unique patterns of selectivity. The two other cleft-like hosts follow two different trends, shallow host (clip) following similar trends to the calixarenes, and the other more closed host (tweezer) binding certain less-methylated amino acids stronger than their methylated counterparts. Molecular modelling sheds some light on the different preferences of the various hosts. The results identify hosts with new selectivities and with affinities in a range that could be useful for biomedical applications. The overall selectivity patterns are explained by a common framework that considers the geometry, depth of binding pockets, and functional group participation across all host classes.